Who owns the MEDEXOMARINE trademark?

The MEDEXOMARINE trademark is owned by ROHTO MEDILUXE EUROPE.

What class is the MEDEXOMARINE trademark registered in?

The MEDEXOMARINE trademark is registered in Class 001 (Chemicals for industrial, scientific & agricultural use).

What is the serial number for MEDEXOMARINE?

The USPTO serial number for MEDEXOMARINE is 79430609.

What is the registration number for MEDEXOMARINE?

MEDEXOMARINE is registered under USPTO registration number 8191022.

MED

USPTO Trademark Record

REGISTERED

MEDEXOMARINE

SN 79430609·Reg 8191022·Filed May 13, 2025

Owner ROHTO MEDILUXE EUROPE

Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fire extinguishing and fire prevention compositions; tempering and soldering preparations; substances for tanning animal skins and hides; adhesives for use in industry; compost, manures, fertilizers; biological preparations for use in industry and science.

MEDEXOMARINE (Serial No. 79430609), Registration No. 8191022, is a registered US trademark filed on May 13, 2025 by ROHTO MEDILUXE EUROPE. This trademark covers Class 001 (Chemicals for industrial, scientific & agricultural use).

early section 8: March 31, 2032

Mark Intelligence

MEDEXOMARINE (Reg. #8191022) is a registered US trademark that has been protecting its owner, ROHTO MEDILUXE EUROPE, since 2025. The mark covers Class 001 (Chemicals for industrial, scientific & agricultural use). Goods and services include Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocesse.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 13, 2025

SERIAL

79430609

REG#

8191022

REGISTERED

Mar 31, 2026

Owner

Applicant

ROHTO MEDILUXE EUROPE

Entity

Corporation (Foreign)

Address

19 boulevard Malesherbes, F-75008 Paris

Country

Attorney

NameAndrew N. Spivak

Law firm

Andrew N. Spivak Mosaic Legal Group, PLLC

Docket

MED-MA-7/CN

Address

4300 Fordham Road, NW, Suite 250, Washington, DC 20016-1950, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 13, 2025

Serial Number79430609

Registration No.8191022

Registration DateMar 31, 2026

Status DateMar 31, 2026

Published for OppositionFeb 10, 2026

Mark TypeStandard characters

Attorney DocketMED-MA-7/CN

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 001Chemicals for industrial, scientific & agricultural use

US codes: 001, 005, 006, 010, 026, 046

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

CHANGE OF NAME/ADDRESS REC'D FROM IB

Aug 13, 2026

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 30, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Mar 31, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 31, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 10, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 10, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 04, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 16, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Jan 14, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jan 14, 2026

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 14, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jan 14, 2026

EXAMINER'S AMENDMENT ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 08, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 08, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 08, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Dec 05, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Nov 20, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Nov 20, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Oct 02, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Oct 01, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 25, 2025

ASSIGNED TO EXAMINER

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Sep 22, 2025

LIMITATION FROM ORIGINAL APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 22, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Sep 22, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 21, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

MEDEXOMARINE

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by ROHTO MEDILUXE EUROPE

Other Marks by Andrew N. Spivak

Resources

Company